Vimarsana
Biggest News Aggregation in the World

Practice Patterns Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Practice Patterns Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Practice Patterns Study Today - Breaking & Trending Today

Pruritus in Nondialysis CKD Tied With Adverse Outcomes - Vimarsana News

Pruritus in Nondialysis CKD Tied With Adverse Outcomes

More than half of patients with nondialysis chronic kidney disease reported bothersome pruritus, or “itchy skin.” Pruritus, or “itchy skin,” also affects patients with nondialysis chronic kidney disease (CKD) and is tied with worse outcomes.

Erythropoietin Resistance Increases Risk of Mortality in Patients with Anemia, CKD - Vimarsana News

Erythropoietin Resistance Increases Risk of Mortality in Patients with Anemia, CKD

Patients on maintenance hemodialysis classified as having a high erythropoietin resistance index had a greater risk of all-cause mortality.

Transfusion Rates High in First 90 Days of Hemodialysis vs Peritoneal Dialysis - Vimarsana News

Transfusion Rates High in First 90 Days of Hemodialysis vs Peritoneal Dialysis

Investigators report results of their analysis of patients in the DOPPS and PDOPPS. Transfusion rates are high within the first few months of hemodialysis, but not peritoneal dialysis.

Few Patients Report Talking About Forgoing Dialysis With Their Nephrologist - Vimarsana News

Few Patients Report Talking About Forgoing Dialysis With Their Nephrologist

Low uptake of conservative kidney management appears to be due to barriers at multiple points of clinical care, according to investigators. A US study describes the discussions and resources around providing conservative kidney management to select patients with kidney failure.

Greater Hemoglobin Variability on ESAs Ups Infection Risk - Vimarsana News

Greater Hemoglobin Variability on ESAs Ups Infection Risk

Patients on hemodialysis treated with ESAs who have higher hemoglobin variability are at higher risk for all-cause mortality and particularly infectious events.